Mereo BioPharma (MREO) Current Taxes (2021)
Mereo BioPharma (MREO) posted quarterly Current Taxes of $2.1 million for Q4 2021.
Mereo BioPharma (MREO) Current Taxes (2021) Analysis & Trends
Mereo BioPharma (MREO) has reported Current Taxes for 1 consecutive years, with $2.1 million the latest figure, recorded in Q4 2021.
- In Q4 2021, Current Taxes changed N/A year-over-year to $2.1 million; the TTM figure through Dec 2021 stood at $2.1 million (changed N/A YoY), while the FY2021 annual figure was $2.1 million, changed N/A from the prior year.
- Current Taxes steadied at $2.1 million in Q4 2021 per MREO's latest filing.
- Across five years, Current Taxes topped out at $2.1 million in Q4 2021 and bottomed at $2.1 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.91 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.87 Bn | 59.68 Bn | 1.37 Bn | 49.00 Mn |
| 4 | Moderna | 58.18 Bn | 53.04 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.96 Bn | 36.87 Bn | 1.53 Bn | 76.32 Mn |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.23 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.79 Bn | 9.40 Bn | 668.28 Mn | 76.36 Mn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.37 Bn | 26.53 Bn | - | - |
| 10 | Mereo BioPharma | 47.86 Mn | 47.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 2.05 Mn |